Docking and molecular dynamics studies for developing Microcin C7 as an alternative drug against diphtheria toxin
by Sumedha Ojha; Subir Kundu
International Journal of Bioinformatics Research and Applications (IJBRA), Vol. 13, No. 3, 2017

Abstract: Some conventional drugs are becoming ineffective these days for the treatment of diseases. This problem arises due to increase in the incidences of drug-resistant pathogens. Thus, there is a need for the development of alternative drugs. These alternative drugs should have the properties against which the microorganisms will not be able to develop resistance. The most promising candidates to be developed as alternative drugs are the antimicrobial peptides. In the present study, the docking studies were performed between the antimicrobial peptide Microcin C7 and the catalytic domain of diphtheria toxin. His21, Gly22, Thr42, Tyr46, Ala62, Tyr65 and Asn69 formed non-bond interactions with Microcin C7. Furthermore, the simulation studies were done to find the stability of the docked complex. The root mean square deviation and root mean square fluctuation results were significant and hence it was predicted that further work can be done on antimicrobial peptide Microcin C7 to develop it as an alternative drug against diphtheria toxin.

Online publication date: Wed, 16-Aug-2017

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Bioinformatics Research and Applications (IJBRA):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com